This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (68)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

RICHARD A. THOMPSON, M.D.; PAUL J. VIGNOS, JR., M.D.

AMA Arch Intern Med. 1959;103(4):551-564.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In recent years, progress has been made in the clinical description and delineation of neuromuscular diseases manifest primarily by skeletal muscle weakness. However, accurate diagnosis in the early stages before the development of advanced muscle involvement is still difficult. It is now recognized that a well-rounded symptomatic treatment program can help in preventing unnecessary complications and in obtaining maximal function from the residual musculature. Such a program will be most effective if efforts are directed early in the disease not only toward physical therapy and orthopedic modalities but also toward the psychologic reactions of these patients.¹ There is a need for laboratory assistance not only in diagnosis but for long-term management as an aid in establishment of prognosis, evaluation of therapeutic effects, and as a guide in setting reasonable goals. Laboratory tests, which have been used in the past, such as urinary creatine and creatinine, reflect the amount of . . . [Full Text PDF of this Article]

Author Affiliations
Cleveland

From the Department of Medicine, Western Reserve University School of Medicine.

Footnotes
Submitted for publication July 24, 1958.

Aided by a grant from the Muscular Dystrophy Association of America, Inc.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?